Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03476941 · ClinicalTrials.gov registry record · Phase 2
Antibiotic Irrigations for Intra-Abdominal Drains
A Phase 2 study of Abdominal Abscess, sponsored by Paolo Goffredo.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT03476941 is a Phase 2 study of Abdominal Abscess that is actively recruiting participants, run by Paolo Goffredo. The registered enrollment target is 50 participants. The trial reports 1 study location across 1 state.
The verdict
NCT03476941, a Phase 2 study of Abdominal Abscess, is actively recruiting participants, sponsored by Paolo Goffredo.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
Intra-abdominal abscesses are pus-filled pouches in the abdominal cavity. Current standard of care includes drain placement in the abscess cavity to reach source control as well as administration of systemic antibiotics. It is common practice to flush the drain on a daily basis to ensure patency. This study aims to analyze the clinical impact of a higher local concentration of antibiotics (rather than normal saline) provided through drain irrigation with an antimicrobial agent (Gentamicin and/or Clindamycin) compare to normal saline.
Conditions Studied
Interventions
- OTHER Placebo
- DRUG Gentamicin Sulfate Inj 20mg/2ml vial for injection
- DRUG Clindamycin phosphate 6 mg/1ml for injection
Study Locations (1)
Iowa
- The University of Iowa - Iowa City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2019-04-01 |
| Est. Completion | 2021-09-01 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03476941
The ClinicalTrials.gov registry entry for NCT03476941 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Paolo Goffredo, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Abdominal Abscess appearing as the primary indexed condition, and to 3 interventions - of which Placebo is the first listed.
NCT03476941 reports 1 study location spanning 1 distinct geographic area - top geographies include Iowa.
Frequently Asked Questions
What is clinical trial NCT03476941 about?
NCT03476941 is a clinical study titled "Antibiotic Irrigations for Intra-Abdominal Drains". Intra-abdominal abscesses are pus-filled pouches in the abdominal cavity. Current standard of care includes drain placement in the abscess cavity to reach source control as well as administration of systemic antibiotics. It is common practice to flush the drain on a daily basis to ensure patency. Th...
What is the current status of trial NCT03476941?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 50 participants. The study started on 2019-04-01. Estimated completion is 2021-09-01.
What conditions does trial NCT03476941 study?
This clinical trial studies the following conditions: Abdominal Abscess.
What interventions are being tested in trial NCT03476941?
The interventions under investigation include: Placebo (OTHER), Gentamicin Sulfate Inj 20mg/2ml vial for injection (DRUG), Clindamycin phosphate 6 mg/1ml for injection (DRUG).
Who is sponsoring clinical trial NCT03476941?
This trial is sponsored by Paolo Goffredo, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03476941 being conducted?
This trial has 1 study location across Iowa. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.